BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27208400)

  • 1. Lateral flow-based antibody testing for Chlamydia trachomatis.
    Gwyn S; Mitchell A; Dean D; Mkocha H; Handali S; Martin DL
    J Immunol Methods; 2016 Aug; 435():27-31. PubMed ID: 27208400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of a rapid test for antibodies to the Chlamydia trachomatis antigen Pgp3.
    Gwyn S; Mkocha H; Randall JM; Kasubi M; Martin DL
    Diagn Microbiol Infect Dis; 2019 Apr; 93(4):293-298. PubMed ID: 30709562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Platforms for Testing Antibody Responses against the
    Gwyn S; Cooley G; Goodhew B; Kohlhoff S; Banniettis N; Wiegand R; Martin DL
    Am J Trop Med Hyg; 2017 Dec; 97(6):1662-1668. PubMed ID: 29016320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the reproducibility of a serological test for antibodies to Chlamydia trachomatis pgp3: A potential surveillance tool for trachoma programs.
    Kaur H; Dize L; Munoz B; Gaydos C; West SK
    J Microbiol Methods; 2018 Apr; 147():56-58. PubMed ID: 29501689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma.
    Gwyn S; Nute AW; Sata E; Tadesse Z; Chernet A; Haile M; Zeru T; Bethea D; Laurent C; Callahan EK; Nash SD; Martin DL
    Am J Trop Med Hyg; 2021 Aug; 105(5):1362-1367. PubMed ID: 34398819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a field test for antibodies against Chlamydia trachomatis during trachoma surveillance in Nepal.
    Sun MJ; Zambrano AI; Dize L; Munoz B; Gwyn S; Mishra S; Martin DL; Sharma S; West SK
    Diagn Microbiol Infect Dis; 2017 May; 88(1):3-6. PubMed ID: 28214223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three serological assays to measure antibody response to Chlamydia antigen Pgp3 in adolescent and young adults with pelvic inflammatory disease.
    Dize L; Martin D; Gwyn S; Perin J; Gaydos C; Trent M
    Int J STD AIDS; 2018 Nov; 29(13):1324-1329. PubMed ID: 30049256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
    Kim JS; Oldenburg CE; Cooley G; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Keenan JD; Gaynor BD; Porco TC; Lietman TM; Martin DL
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007127. PubMed ID: 30689671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of an enzyme-linked immunosorbent assay for the detection of antibodies to a common urogenital derivative of Chlamydia trachomatis plasmid-encoded PGP3.
    Winstanley CE; Ramsey KH; Marsh P; Clarke IN
    J Immunol Methods; 2017 Jun; 445():23-30. PubMed ID: 28283408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serology for trachoma surveillance after cessation of mass drug administration.
    Martin DL; Bid R; Sandi F; Goodhew EB; Massae PA; Lasway A; Philippin H; Makupa W; Molina S; Holland MJ; Mabey DC; Drakeley C; Lammie PJ; Solomon AW
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003555. PubMed ID: 25714363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area.
    West SK; Munoz B; Kaur H; Dize L; Mkocha H; Gaydos CA; Quinn TC
    Sci Rep; 2018 Feb; 8(1):3520. PubMed ID: 29476106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent class modeling to compare testing platforms for detection of antibodies against the Chlamydia trachomatis antigen Pgp3.
    Wiegand RE; Cooley G; Goodhew B; Banniettis N; Kohlhoff S; Gwyn S; Martin DL
    Sci Rep; 2018 Mar; 8(1):4232. PubMed ID: 29523810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of immunoassays for the Chlamydia trachomatis antigen Pgp3 using a chimeric monoclonal antibody.
    Goodhew B; Tang X; Goldstein J; Lee J; Martin D; Gwyn S
    Sci Rep; 2023 May; 13(1):7281. PubMed ID: 37142607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
    Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection.
    Ghaem-Maghami S; Ratti G; Ghaem-Maghami M; Comanducci M; Hay PE; Bailey RL; Mabey DC; Whittle HC; Ward ME; Lewis DJ
    Clin Exp Immunol; 2003 Jun; 132(3):436-42. PubMed ID: 12780690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection.
    Wills GS; Horner PJ; Reynolds R; Johnson AM; Muir DA; Brown DW; Winston A; Broadbent AJ; Parker D; McClure MO
    Clin Vaccine Immunol; 2009 Jun; 16(6):835-43. PubMed ID: 19357314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children.
    West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC
    Sci Rep; 2020 Sep; 10(1):15225. PubMed ID: 32938957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections.
    Blomquist PB; Mighelsen SJ; Wills G; McClure E; Ades AE; Kounali D; Dunbar JK; McClure MO; Soldan K; Woodhall SC; Horner P
    PLoS One; 2018; 13(12):e0208652. PubMed ID: 30557408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati.
    Cama A; Müller A; Taoaba R; Butcher RMR; Itibita I; Migchelsen SJ; Kiauea T; Pickering H; Willis R; Roberts CH; Bakhtiari A; Le Mesurier RT; Alexander NDE; Martin DL; Tekeraoi R; Solomon AW;
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005863. PubMed ID: 28898240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and utility of 2 Chlamydia trachomatis Pgp3 serological assays for seroprevalence studies among women in the United States.
    Danavall DC; Gwyn S; Anyalechi GE; Bowden KE; Hong J; Kirkcaldy RD; Bernstein KT; Kersh EN; Martin D; Raphael BH
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115480. PubMed ID: 34325205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.